Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
29.34
+0.94 (3.31%)
Dec 20, 2024, 4:00 PM EST - Market closed
Akero Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 2,048 | 1,301 | 2,563 | 738 | 896 | 634 | |
| Market Cap Growth | -29.17% | -49.24% | 247.29% | -17.63% | 41.33% | - | |
| Enterprise Value | 1,297 | 714 | 2,199 | 524 | 606 | 486 | |
| Last Close Price | 29.34 | 23.35 | 54.80 | 21.15 | 25.80 | 22.20 | |
| PB Ratio | 2.77 | 2.43 | 7.85 | 4.36 | 3.46 | 4.92 | |
| P/TBV Ratio | 2.70 | 2.43 | 7.85 | 4.36 | 3.46 | 4.92 | |
| Debt / Equity Ratio | 0.05 | 0.05 | 0.03 | 0.01 | 0.01 | 0.00 | |
| Quick Ratio | 16.57 | 28.75 | 18.42 | 7.49 | 20.47 | 14.56 | |
| Current Ratio | 17.25 | 29.27 | 18.61 | 7.70 | 20.70 | 14.73 | |
| Return on Equity (ROE) | -35.90% | -35.22% | -45.20% | -47.11% | -40.89% | -42.99% | |
| Return on Assets (ROA) | -23.17% | -23.07% | -26.07% | -26.90% | -24.35% | -26.51% | |
| Return on Capital (ROIC) | -24.33% | -24.04% | -28.33% | -29.25% | -25.73% | -28.02% | |
| Earnings Yield | -11.58% | -11.67% | -4.37% | -13.66% | -8.84% | -6.90% | |
| FCF Yield | -10.38% | -11.17% | -3.61% | -10.80% | -7.92% | -5.62% | |
| Buyback Yield / Dilution | -25.99% | -34.84% | -11.94% | -10.69% | -108.77% | -14474.75% | |
| Total Shareholder Return | -25.99% | -34.84% | -11.94% | -10.69% | -108.77% | -14474.75% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.